Barclays analyst Tavy Rosner raised the firm’s price target on Sapiens to $28 from $24 and keeps an Underweight rating on the shares. The analyst cites “strong fundamentals” post the Q2 beat for the target raise, but still thinks the stock’s outperformance year-to-date in addition to lingering macro challenges leave little scope for further upside.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SPNS: